STAGE IV PENILE CANCER AJCC V8
Clinical trials for STAGE IV PENILE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PENILE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PENILE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men with advanced penile cancer: targeted drug trial opens
Disease control Recruiting nowThis study is testing whether the drug enfortumab vedotin can help control advanced penile cancer that has spread or cannot be surgically removed. The drug is designed to target cancer cells specifically and deliver a cancer-killing agent directly to them. Researchers will measur…
Matched conditions: STAGE IV PENILE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: STAGE IV PENILE CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC